Anticoagulant effect of Tri Bao Hoan in an experimental thrombosis model

Pham Thi Van Anh, Vu Thi Lan, Nguyen Chi Duong, Nguyen Trieu Van, Vu Quang Huy, Nguyen Thi Thanh Loan

Nội dung chính của bài viết

Tóm tắt

The purpose of this study was to evaluate the anticoagulant effects of Tri Bao Hoan in a lipopolysaccharide (LPS)-induced thrombosis model using Wistar rats. Tri Bao Hoan and rivaroxaban were administered orally for seven consecutive days. One hour after the final dose, LPS (3 mg/kg) was injected via the tail vein to induce thrombosis. Blood samples were collected four hours after LPS administration to assess the study parameters. Our findings indicated that Tri Bao Hoan at 0.36 pill/kg/day exerted significant anticoagulant effects by increasing platelet count and fibrinogen concentration, as well as prolonging prothrombin time (PT) and activated partial thromboplastin time (aPTT) compared with the vehicle-treated thrombosis group (p < 0.05). Tri Bao Hoan at 0.12 pill/kg/day did not show statistically significant changes in these parameters (p > 0.05). Regarding biochemical findings, Tri Bao Hoan at 0.36 pill/kg/day significantly reduced serum AST activity in the vehicle-treated thrombosis group (p < 0.05), whereas AST activity, urea and creatinine concentration remained statistically unchanged at both doses (p > 0.05). In conclusion, Tri Bao Hoan at 0.36 pill/kg/day demonstrated a significant anticoagulant effect in Wistar rats with LPS-induced thrombosis.

Chi tiết bài viết

Tài liệu tham khảo

1. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thrombosis and Haemostasis. 2001;85(6):958-65.
2. Wendelboe AM, Raskob GE. Global Burden of Thrombosis: Epidemiologic Aspects. Circulation Research. 2016;118(9):1340-7.
3. Kholmukhamedov A, Subbotin D, Gorin A, et al. Anticoagulation Management: Current Landscape and Future Trends. Journal of Clinical Medicine. 2025;14(5).
4. Zhu Z, Huang R, He H, et al. Emerging trends in anticoagulation therapy: a bibliometric analysis of DOACs and endogenous coagulation pathway inhibitors. Naunyn–Schmiedeberg’s Archives of Pharmacology. 2025.
5. Chen C, Yang FQ, Zhang Q, et al. Natural Products for Antithrombosis. Evidence-Based Complementary and Alternative Medicine. 2015;2015:876426.
6. Weng Y, Yao J, Sparks S, et al. Nattokinase: An oral antithrombotic agent for the prevention of cardiovascular disease. International Journal of Molecular Sciences. 2017;18(3).
7. Zhu Z, Deng X, Xie W, et al. Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review. Animal Models and Experimental Medicine. 2024;7(5):653-672.
8. Wang L, Huang S, Chen B, et al. Characterization of the anticoagulative constituents of Angelicae Sinensis Radix and their metabolites in rats by HPLC-DAD-ESI-IT-TOF-MSn. Planta Medica. 2016;82(4):362-70.
9. Yang T, Jia M, Mei Q, et al. Effects of Angelica polysaccharide on blood coagulation and platelet aggregation. Journal of Chinese Medicinal Materials. 2002;25(5):344-345.
10. Gong Y, Fan L, Wang L, et al. Flos Sophorae Immaturus: Phytochemistry, bioactivities, and its potential applications. Food Reviews International. 2023;39(6):3185-3203.
11. Wang B, Wu SM, Wang T, et al. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model. Chinese Medical Journal. 2012;125(10):1753-9.
12. Pham Thi Van Anh, Nguyen Thi Thanh Loan, Mai Phuong Thanh, et al. Effects of TD-HK01 capsules on blood coagulation and fibrinolysis in experimental models. Journal of Medical Research. 2018;115(6):80-89.
13. Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterranean Journal of Hematology and Infectious Diseases. 2010;2(3):e2010024.
14. Perzborn E, Hirth-Dietrich C, Fischer E, et al. Rivaroxaban has protective effects in a model of disseminated intravascular coagulation (DIC) in Rats. Blood. 2007;110(11):935.
15. Shuai S, Yue G. Ferulic acid, a potential antithrombotic drug. Journal of Lung Health and Diseases. 2018;2(2).
16. Gogoi D, Chattopadhyay P, Dolui SK, et al. Studies on in vivo antithrombotic activity of quercetin, a natural flavonoid isolated from a traditional medicinal plant, African eggplant (Solanum indicum). Journal of Ethnopharmacology. 2024;335:118686.
17. Stochmal A, Rolnik A, Skalski B, et al. Antiplatelet and anticoagulant activity of isorhamnetin and its derivatives isolated from sea buckthorn berries, measured in whole blood. Molecules. 2022;27(14):4429.
18. World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. WHO; Geneva, Switzerland, 2000, 35.
19. Saitoh H, Sakaguchi M, Miruno F, et al. Histopathological Analysis of Lipopolysaccharide-Induced Liver Inflammation and Thrombus Formation in Mice: The Protective Effects of Aspirin. Current Issues in Molecular Biology. 2024;46(12):14291-14303.